Stelara injection – Product Description
Stelara injection contains the active ingredient ustekinumab. This biologic medication targets immune pathways that drive inflammatory diseases. Doctors prescribe Stelara for individuals who live with moderate to severe plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The therapy focuses on immune system regulation through selective cytokine inhibition.
Ustekinumab blocks the activity of interleukin-12 (IL-12) and interleukin-23 (IL-23). These cytokines influence inflammatory responses inside the immune system. Excess activity of these proteins can trigger chronic inflammation in skin, joints, and the gastrointestinal tract. Stelara reduces this inflammatory signaling and supports immune balance.
Plaque psoriasis causes red, thickened patches of skin covered with silvery scales. Stelara helps reduce plaque formation, itching, and skin irritation. Patients who receive treatment often experience clearer skin and improved comfort. Doctors may recommend Stelara for individuals who require systemic therapy or phototherapy.
Psoriatic arthritis affects joints and connective tissues. The condition may cause pain, swelling, stiffness, and reduced mobility. Stelara helps control inflammation that damages joints. Many treatment plans combine Stelara with lifestyle management and physician monitoring.
stelara injection
Crohn’s disease and ulcerative colitis involve chronic inflammation in the digestive tract. Stelara targets immune pathways associated with intestinal inflammation. Patients may experience relief from abdominal pain, diarrhea, fatigue, and digestive discomfort. Gastroenterologists evaluate disease severity before initiating treatment.
Healthcare professionals administer Stelara through injection. Initial treatment often begins with an intravenous infusion followed by scheduled subcutaneous injections. Physicians determine dosage schedules according to body weight, diagnosis, and clinical response.
Patients must receive treatment under medical supervision. Doctors evaluate infection history, immune conditions, and current medications before prescribing Stelara. Medical monitoring supports safe treatment and helps manage potential immune-related effects.
Stelara plays an important role in modern biologic therapy. The targeted mechanism helps control inflammation without broad immune suppression. Physicians rely on this treatment option for patients who require advanced immune-modulating therapy for chronic inflammatory diseases.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Stelara |
| Active Ingredient | Ustekinumab |
| Drug Class | Monoclonal Antibody / Biologic |
| Mechanism of Action | Blocks interleukin-12 and interleukin-23 |
| Dosage Form | Injection |
| Administration Route | Subcutaneous / Intravenous |
| Indications | Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis |
| Target System | Immune System |
| Manufacturer | Janssen Biotech |
| Storage | Refrigerated between 2°C and 8°C |
Stelara provides a targeted biologic option for patients who require immune regulation for chronic inflammatory diseases. Doctors continue to rely on this therapy for effective inflammation control and improved quality of life.






Reviews
There are no reviews yet.